Medicare Compliance & Reimbursement

Advisory Opinions:

OIG NIXES COPAY SUBSIDY

Drugmakers can’t use Medicare to subsidize patient assistance programs for financially needy beneficiaries, the HHS Office of Inspector General reaffirmed in an advisory opinion released Feb. 12 (No. 03-3). In the opinion, the OIG considers a pharmaceutical manufacturer’s proposal to modify its existing PAP to pay Medicare Part B cost-sharing amounts for needy patients who use its post-organ transplant immunosuppressive products. [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Medicare Compliance & Reimbursement

View All